Serendipity in diagnostic imaging: Magnetic resonance imaging of the breast

Journal of the National Cancer Institute

Volumn 90, Issue 23, 1998, Pages 1792-1800

  Lawrence, William F ^a   Liang, Wenchi ^a   Mandelblatt, Jeanne S ^a   Gold, Karen F ^a   Freedman, Matthew ^b   Ascher, Susan M ^b   Trock, Bruce J ^a   Chang, Polun ^c  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; CANCER RISK; DIAGNOSTIC IMAGING; HUMAN; MAMMOGRAPHY; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; STATISTICAL MODEL;

EID: 0032477330     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.23.1792     Document Type: Article

References (71)

1. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years [published erratum appears in Can Med Assoc J 1993;148:718]. CMAJ 1992;147:1459-76.
2. Osteen RT, Cady B, Chmiel JS, Clive RE, Doggett RL, Friedman MA, et al. 1991 national survey of carcinoma of the breast by the Commission on Cancer. J Am Coll Surg 1994;178:213-9.
3. Winchester DP, Senen S, Immerman S, Blum M. A systematic approach to the evaluation and management of breast masses. Cancer 1983;51(12 Suppl):2535-9.
4. Yankaskas BC, Knelson MH, Abernathy ML, Cuttino JT Jr, Clark RL. Needle localization biopsy of occult lesions of the breast: experience in 199 cases. Invest Radiol 1988;23:729-33.
5. Cardenosa G, Eklund GW. Rate of compliance with recommendations for additional mammographic views and biopsies. Radiology 1991;181: 359-61.
6. Goedde TA, Frykberg ER, Crump JM, Lay SF, Turetsky DB, Linden SS. The impact of mammography on breast biopsy. Am Surg 1992;58:661-6.
7. Layfield LJ, Chrischilles EA, Cohen MB, Bottles K. The palpable breast nodule. A cost-effectiveness analysis of alternate diagnostic approaches. Cancer 1993;72:1642-51.
8. Lindfors KK, Rosenquist CJ. Needle core biopsy guided with mammography: a study of cost-effectiveness. Radiology 1994;190:217-22.
9. Liberman L, Fahs MC, Dershaw DD, Bonaccio E, Abramson AF, Cohen MA, et al. Impact of stereotaxic core breast biopsy on cost of diagnosis. Radiology 1995;195:633-7.
10. Hillner BE, Bear HD, Fajardo LL. Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model. Acad Radiol 1996;3:351-60.
11. Gram IT, Lund E, Slenker SE. Quality of life following a positive mammogram. Br J Cancer 1990;62:1018-22.
12. Parker RG. The "cost-effectiveness" of radiology and radiologists. Radiology 1993;189:363-9.
13. Frankel SD, Sickles EA. Morphologic criteria for interpreting abnormalities seen at breast MR imaging [editorial]. Radiology 1997;202:633-4.
14. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintomammography using technetium-99m sestamibi. Eur J Nucl Med 1994;21:357-62.
15. Heywang-Koebrunner SH. Diagnosis of breast cancer with MR - review after 1250 patient examinations. Electromedica 1993;61:43-52.
16. McNaughton Collins M, Ransohoff DF, Barry MJ. Early detection of prostate cancer. Serendipity strikes again. JAMA 1997;278:1516-9.
17. Sox HC, Blatt MA, Higgins MC, Marton KI. Medical decision making. Boston (MA): Butterworth-Heinemann; 1988.
18. Chalmers TC, Levin H, Sacks HS, Reitman D, Berrier J, Nagalingam R. Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large cooperative trials. Stat Med 1987;6:315-28.
19. Chalmers TC, Berrier J, Sacks HS, Levin H, Reitman D, Nagalingam R. Meta-analysis of clinical trials as a scientific discipline: II. Replicate variability and comparison of studies that agree and disagree. Stat Med 1987; 6:733-44.
20. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med 1987;316:450-5.
21. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987;10:224-33.
22. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820-6.
23. Olkin I. Statistical and theoretical considerations in meta-analysis. J Clin Epidemiol 1995;48:133-46.
24. Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer: the Health Insurance Plan Project and its sequelae, 1963-1986. Baltimore (MD): The Johns Hopkins University Press; 1988.
25. Chamberlain J, Coleman D, Ellman R, Moss S, Thomas B, Price J, et al. Sensitivity and specificity of screening in the UK Trial of Early Detection of Breast Cancer. In: Miller AB, Chamberlain J, Daye NE, Hakama M, Prorok PC, editors. Cancer screening. Cambridge (U.K.): Cambridge University Press; 1991. p. 3-17.
26. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years [published erratum appears in Can Med Assoc J 1993;148:718]. CMAJ 1992;147:1477-88.
27. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993;85:1644-56.
28. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Likelihood ratios for modern screening mammography: Risk of breast cancer based on age and mammographic interpretation. JAMA 1996;276:39-43.
29. Fryback DG. Bayes' theorem and conditional nonindependence of data in medical diagnosis. Comput Biomed Res 1978;11:423-34.
30. Chang P, Fryback DG. A simulation model of breast cancer natural history. Med Decis Making 1992;12:345.
31. Chang P, Fryback DG. Rethinking the benefits of breast cancer screening. Med Decis Making 1993;13:382.
32. Ries LA, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, editors. SEER Cancer Statistics Review. 1973-1994, National Cancer Institute. NIH Publ No. 97-2789. Bethesda (MD); 1997.
33. U.S. Bureau of the Census, Statistical abstract of the United States: 1996, 116th edition. Washington (DC); 1996.
34. Colditz GA, Rosner BA, Speizer FE. Risk factors for breast cancer according to family history of breast cancer. For the Nurses' Health Study Research Group. J Natl Cancer Inst 1996;88:365-71.
35. Colditz GA, Willett WC, Hunter DJ, Stampfer MJ, Manson JE, Hennekens CH, et al. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study [published erratum appears in JAMA 1993; 270:1548]. JAMA 1993;270:338-43.
36. Schwartz AG, King MC, Belle SH, Satariano WA, Swanson GM. Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst 1985;75:665-8.
37. Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database. JAMA 1993;270: 1563-8.
38. Sattin RW, Rubin GL, Webster LA, Huezo CM, Wingo PA, Ory HW, et al. Family history and the risk of breast cancer. JAMA 1985;253:1908-13.
39. Parazzini F, La Vecchia C, Negri E, Franceschi S, Tozzi L. Family history of breast, ovarian and endometrial cancer and risk of breast cancer. Int J Epidemiol 1993;22:614-8.
40. Calle EE, Martin LM, Thun MJ, Miracle HL, Heath CW Jr. Family history, age, and risk of fatal breast cancer. Am J Epidemiol 1993;138:675-81.
41. Bain C, Speizer FE, Rosner B, Belanger C, Hennekens CH. Family history of breast cancer as a risk indicator for the disease. Am J Epidemiol 1980; 111:301-8.
42. Dupont WD, Page DL. Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol 1987;125:769-79.
43. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
44. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 1988;128:467-77.
45. McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D. Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group. Cancer 1992;69:1408-14.
46. Fleiss JL. Statistical methods for rates and proportions. New York (NY): John Wiley & Sons; 1981.
47. Rice JA. Mathematical statistics and data analysis. Pacific Grove (CA): Wadsworth & Brooks; 1988.
48. Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making 1993; 13:313-21.
49. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 1985;5:157-77.
50. Peer PG, Verbeek AL, Straatman H, Hendriks JH, Holland R. Age-specific sensitivities of mammographic screening for breast cancer. Breast Cancer Res Treat 1996;38:153-60.
51. Robertson CL. A private breast imaging practice: medical audit of 25,788 screening and 1077 diagnostic examinations. Radiology 1993;187:75-9.
52. Burhenne HJ, Burhenne LW, Goldberg F, Hislop TG, Worth AJ, Rebbeck PM, et al. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification. AJR Am J Roentgenol 1994;162:1067-71.
53. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. New results from the Swedish two-country trial. Cancer 1995;75:2507-17.
54. D'Orsi CJ, Kopans DB. Mammographic feature analysis. Semin Roentgenol 1993;28:204-30.
55. Cross MJ, Harms SE, Cheek JH, Peters GN, Jones RC. New horizons in the diagnosis and treatment of breast cancer using magnetic resonance imaging. Am J Surg 1993;166:749-53.
56. Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187:493-501.
57. Perman WH, Heiberg EV, Herrmann VM. Half-Fourier, three-dimensional technique for dynamic contrast-enhanced MR imaging of both breasts and axillae: initial characterization of breast lesions. Radiology 1996;200: 263-9.
58. Page DL, Dupont WD, Roger LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 1982;49:751-8.
59. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. The management of ductal carcinoma in situ (DCIS). CMAJ 1998;158 (Suppl 3):S27-34.
60. Welch HG, Black WC. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med 1997;127:1023-8.
61. Easton DF, Ford D, Bishop DT, et al. Breast and ovarian cancer incidence in BRCA-1 mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995;56:265-71.
62. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2 [published erratum appears in Nature 1996;379:749]. Nature 1995;378:789-92.
63. Boetes C, Barentsz JO, Mus RD, van der Sluis RF, van Erning LJ, Hendriks JH, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 1994;193: 777-81.
64. Gilles R, Guinebretiere JM, Lucidarme O, Cluzel P, Janaud G, Finet JF, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging [published erratum appears in Radiology 1944; 193:285]. Radiology 1994;191:625-31.
65. Turkat TJ, Klein BD, Polan RL, Richman RH. Dynamic MR mammography: a technique for potentially reducing the biopsy rate for benign breast disease. J Magn Reson Imaging 1994;4:563-8.
66. Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995;197:387-95.
67. Heiberg EV, Perman WH, Herrmann VM, Janney CG. Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. Magn Reson Imaging 1996;14:337-48.
68. Obdeijn IM, Kuijpers TJ, van Dijk P, Wiggers T, Oudkerk M. MR lesion detection in a breast cancer population. J Magn Reson Imaging 1996;6:849-54.
69. Bone B, Pentek Z, Perbeck L, Veress B. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol 1997;38(4 Pt 1):489-96.
70. Helbich TH, Becherer A, Trattnig S, Leitha T, Kelkar P, Seifert M, et al. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography. Radiology 1997;202:421-9.
71. Nunes LW, Schnall MD, Orel SG, Hochman MG, Langlotz CP, Reynolds CA, et al. Breast MR imaging: interpretation model. Radiology 1997;202: 833-41.